These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28758335)

  • 1. Discordant rapid HIV tests: lessons from a low-resource community.
    Adetunji AA; Kuti MA; Audu RA; Muyibi SA; Imhansoloeva M; Mosuro OA; Solanke EA; Akpa OM; Irabor AE; Ladipo M; Berzins B; Robertson K; Ogunniyi A; Adewole IF; Taiwo BO
    HIV Med; 2018 Jan; 19(1):72-76. PubMed ID: 28758335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test.
    Rosenberg NE; Kamanga G; Phiri S; Nsona D; Pettifor A; Rutstein SE; Kamwendo D; Hoffman IF; Keating M; Brown LB; Ndalama B; Fiscus SA; Congdon S; Cohen MS; Miller WC
    J Infect Dis; 2012 Feb; 205(4):528-34. PubMed ID: 22207651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fourth generation Alere
    Livant E; Heaps A; Kelly C; Maharaj R; Samsunder N; Nhlangulela L; Karugaba P; Panchia R; Marrazzo J; Chirenje ZM; Parikh UM;
    J Clin Virol; 2017 Sep; 94():15-21. PubMed ID: 28710996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Testing Algorithm Performance in a Low-Prevalence Environment.
    Martin EG; Cornett J; Mohammed DY; Salaru G
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S35-S40. PubMed ID: 31977973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast.
    Masciotra S; Luo W; Youngpairoj AS; Kennedy MS; Wells S; Ambrose K; Sprinkle P; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e54-8. PubMed ID: 23911678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of HIV Status in African Adults With Discordant HIV Rapid Tests.
    Fogel JM; Piwowar-Manning E; Donohue K; Cummings V; Marzinke MA; Clarke W; Breaud A; Fiamma A; Donnell D; Kulich M; Mbwambo JK; Richter L; Gray G; Sweat M; Coates TJ; Eshleman SH
    J Acquir Immune Defic Syndr; 2015 Aug; 69(4):430-8. PubMed ID: 25835607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Alere Determine HIV-1/2 Ag/Ab Combo rapid test for acute HIV infection: a case report.
    Lanzafame M; Zorzi A; Rigo F; Adami I; Del Bravo P; Tonolli E; Concia E; Azzini AM
    Infez Med; 2015 Mar; 23(1):48-50. PubMed ID: 25819051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performances of fourth generation HIV antigen/antibody assays on filter paper for detection of early HIV infections.
    Kania D; Truong TN; Montoya A; Nagot N; Van de Perre P; Tuaillon E
    J Clin Virol; 2015 Jan; 62():92-7. PubMed ID: 25464967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 4th-Generation HIV Antigen/Antibody Combination Assay With 3rd-Generation HIV Antibody Assays for the Occurrence of False-Positive and False-Negative Results.
    Muthukumar A; Alatoom A; Burns S; Ashmore J; Kim A; Emerson B; Bannister E; Ansari MQ
    Lab Med; 2015; 46(2):84-9; quiz e28-9. PubMed ID: 25918186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis Programs.
    Delaugerre C; Antoni G; Mahjoub N; Pialoux G; Cua E; Pasquet A; Hall N; Tremblay C; Cotte L; Capitant C; Chaix ML; Meyer L; Molina JM;
    J Infect Dis; 2017 Aug; 216(3):382-386. PubMed ID: 28666370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV single staging algorithm: integration and maximization of resources by reducing time between HIV diagnosis and treatment.
    Bennett B; Hardy B; Fordan S; Haddock-Morilla L; Rowlinson MC; Crowe S
    J Clin Virol; 2013 Dec; 58 Suppl 1():e34-7. PubMed ID: 23993447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
    Dubravac T; Gahan TF; Pentella MA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia.
    Zachary D; Mwenge L; Muyoyeta M; Shanaube K; Schaap A; Bond V; Kosloff B; de Haas P; Ayles H
    BMC Infect Dis; 2012 Aug; 12():183. PubMed ID: 22871032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Multispot rapid HIV-1/HIV-2 differentiation assay is comparable with the Western blot and an immunofluorescence assay at confirming HIV infection in a prospective study in three regions of the United States.
    Pandori MW; Westheimer E; Gay C; Moss N; Fu J; Hightow-Weidman LB; Craw J; Hall L; Giancotti FR; Mak ML; Madayag C; Tsoi B; Louie B; Patel P; Owen SM; Peters PJ
    J Clin Virol; 2013 Dec; 58 Suppl 1():e92-6. PubMed ID: 24342485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Performance of Two Rapid Tests for Detection of HIV-1 and -2 in High- and Low-Prevalence Populations in Nigeria.
    Manak MM; Njoku OS; Shutt A; Malia J; Jagodzinski LL; Milazzo M; Suleiman A; Ogundeji AA; Nelson R; Ayemoba OR; O'Connell RJ; Singer DE; Michael NL; Peel SA
    J Clin Microbiol; 2015 Nov; 53(11):3501-6. PubMed ID: 26311857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Determine™ fourth generation HIV rapid assay.
    Brauer M; De Villiers JC; Mayaphi SH
    J Virol Methods; 2013 Apr; 189(1):180-3. PubMed ID: 23391823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.
    Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J
    J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay.
    Kfutwah A; Lemée V; Ngono HV; De Oliveira F; Njouom R; Plantier JC
    J Clin Virol; 2013 Dec; 58 Suppl 1():e70-5. PubMed ID: 24342480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.